Skip to content
Gregg Girvan /

The End of Humira’s Monopoly

Why did it take two decades to bring a competitor to the popular but costly drug?
Publix First To Offer Free Antibiotics To Customers
A pharmacy manager at a Publix in Miami. (Photo by Joe Raedle/Getty Images)

Over the past 20 years, the biotech company AbbVie has raked in $200 billion in revenue just from sales of its drug Humira, an unprecedented amount in pharmaceutical history. Humira was initially approved to treat rheumatoid arthritis but later earned FDA approval to treat a host of inflammatory diseases.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Gregg Girvan is a resident fellow for the Foundation for Research on Equal Opportunity.

More We Think You’d Like

Loading